Skip to content
HowShorted

Sorrento Therapeutics, Inc. short interest in 2018

In 2018, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 4.07% of shares outstanding on 12 Jan 2018 to 16.54% on 31 Dec 2018, a change of +12.47 percentage points. The year's high was 22.49% on 29 Jun 2018 and its low 3.92% on 31 Jan 2018, averaging 14.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.81 days on 30 Nov 2018. Full history: Sorrento Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Sorrento Therapeutics, Inc. in 2018

2018 in figures

Start of year
4.07% (12 Jan 2018)
End of year
16.54% (31 Dec 2018)
Change
+12.47 pp
High
22.49% (29 Jun 2018)
Low
3.92% (31 Jan 2018)
Average
14.93%
Highest days to cover
19.81 (30 Nov 2018)
SEC filings marked
4

Every report in 2018

Sorrento Therapeutics, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20184.07%1.26
31 Jan 20183.92%1.00
15 Feb 20184.73%1.32
28 Feb 20185.60%1.32
15 Mar 20189.36%1.78
29 Mar 201813.60%2.0210-K filed
13 Apr 201817.27%4.72
30 Apr 201818.92%7.73
15 May 201818.00%8.4410-Q filed
31 May 201817.36%8.99
15 Jun 201818.44%10.50
29 Jun 201822.49%5.38
13 Jul 201820.72%9.99
31 Jul 201820.37%10.40
15 Aug 201816.17%16.7310-Q filed
31 Aug 201816.41%18.93
14 Sep 201817.11%12.83
28 Sep 201817.46%9.60
15 Oct 201816.57%11.04
31 Oct 201815.84%12.66
15 Nov 201815.57%10.6310-Q filed
30 Nov 201816.22%19.81
14 Dec 201815.68%12.27
31 Dec 201816.54%9.87

See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.